CME Group AAQS
The The AAQS of CME Group (CME) as of Nov 12, 2026 is 8. In the previous year, The AAQS was 8.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
8
YoY
0.00%
Last updated:
CME Group has a current AAQS of 8.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock CME Group in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock CME Group in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The CME Group AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
8.00 USD
Jan 1, 2019
8.00 USD
Jan 1, 2020
8.00 USD
Jan 1, 2021
8.00 USD
Jan 1, 2022
8.00 USD
Jan 1, 2023
8.00 USD
Jan 1, 2024
8.00 USD
Jan 1, 2025
8.00 USD
| YEAR | AAQS | YoY |
|---|---|---|
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | 0.00% | |
| 8 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
CME Group Stock analysis
What does CME Group do? CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, is an American exchange and trading platform for futures and options. It has become a global leader in derivatives trading volume. CME Group operates multiple exchange platforms specializing in various asset classes, with the most well-known being the Chicago Mercantile Exchange (CME) for financial futures and derivatives. The company's history dates back to the late 19th century when agricultural futures trading began in Chicago. It was formed by the merger of Chicago Mercantile Exchange Holdings Inc. and the Chicago Board of Trade in 2007, acquiring the New York Mercantile Exchange (NYMEX) and Kansas City Board of Trade (KCBT) in subsequent years. CME Group offers a wide range of futures and options contracts based on different asset classes, with a focus on currencies, interest rates, stock indexes, energy, and agriculture. The company operates internationally and has a strong presence in regulatory compliance. It provides clearing services to minimize counterparty risk in futures transactions. Notable products offered by CME Group include currency futures (Euro FX, Japanese Yen, Swiss Franc, British Pound Sterling), stock index futures (S&P 500, NASDAQ-100, Dow Jones Industrial Average), energy futures (oil, gas, electricity), agricultural futures (corn, soybeans, wheat), as well as newer offerings such as Bitcoin futures and Micro-E-mini Futures. CME Group's business model centers on providing a secure and transparent trading platform for hedging risks and generating capital returns. It earns revenue from fees charged for trading and clearing futures contracts. The company is highly regarded in the industry for its innovation and global market leadership. CME Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about CME Group stock
The AAQS of CME Group is 8 in 2025.
On Eulerpool you can find the complete historical development of The AAQS CME Group since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — CME Group
All Key Metrics — CME Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth